Frontierby eninvs

Language: EN / RU

Rusagro H1 2026: Revenue +9.1% but EBITDA -28.6% and Net Profit -98.8% as Margins Collapse

Rusagro reported H1 2026 revenue of RUB 183.0 bn (+9.1% y/y), but profitability deteriorated sharply: EBITDA fell 28.6% y/y to RUB 13.8 bn and net profit collapsed 98.8% y/y to RUB 55.9 m. Q2 2026 alone showed revenue of RUB 91.5 bn, EBITDA of RUB 6.9 bn and net profit of RUB 27.9 m. The revenue growth decelerated from +13.6% in H2 2025 to +9.1% in H1 2026, while the EBITDA decline moderated from -24.2% in H2 2025 to -28.6% in H1 2026 — still deeply negative. The story is one of margin compression overwhelming top-line growth.

H1 2026 vs H1 2025: y/y growth

Revenue9.1EBITDA-29Net Profit-990−9999
% y/y

Margin collapse drives the miss

The divergence between revenue and profit is stark. H1 2026 EBITDA margin fell to 7.5% (13,781.666 / 183,039.298) from 11.5% in H1 2025 (19,314.889 / 167,774.391), a loss of roughly 4 percentage points. Net margin collapsed to 0.03% from 2.9% a year earlier. Q2 2026 was similarly weak: EBITDA margin of 7.5% (6,890.666 / 91,519.298) and net margin of 0.03% (27.939 / 91,519.298). The company is growing volumes/revenue but at sharply lower profitability — likely reflecting cost inflation, weaker pricing, or a mix shift toward lower-margin segments. No segment-level breakdown was provided in the facts, so we cannot attribute the decline to specific business lines.

Key figures (RUB m)

MetricH1 2025H1 2026Change
Revenue167,774.391183,039.298+9.1%
EBITDA19,314.88913,781.666-28.6%
Net Profit4,831.32755.878-98.8%
EBITDA margin11.5%7.5%-4.0 pp
Net margin2.9%0.03%-2.9 pp

Outlook

The key question for H2 2026 is whether the margin trough has been reached. The H1 2026 EBITDA decline of -28.6% is worse than H2 2025's -24.2%, indicating no stabilization yet. Revenue growth, while positive at +9.1%, is decelerating from +13.6% in H2 2025. With net profit near zero, the company has little buffer against further cost pressure. Investors should watch for any management commentary on cost inflation, pricing, and segment mix — none of which was provided in the facts. The balance sheet remains leveraged, with net debt rising over the past 12 months, limiting flexibility.

Open the company's financial profile RAGR →

See also: market overview · valuation map · stock screeners